Alexander A. Fitzpatrick

Companies

• Silverback TherapeuticsGeneral counsel Dec 1, 2022 to now¹
• Evofem Biosciences, Inc.General counsel Jan 18, 2018 to Feb 23, 2022²
• Verenium CorporationGeneral counsel Nov 12, 2010 to Nov 4, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Silverback Therapeutics SPRY90,910 shares⁴$389.5K at $4.29Jun 12, 2026
• EBEvofem Biosciences, Inc. EVFM516,422 shares⁵$3.5K at $0.01Feb 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 12, 2026Sold 3,355 shares at $10.00 of Silverback Therapeutics⁴
• May 20, 2025Sold 102,969 shares at $14.10 of Silverback Therapeutics⁶
• May 20, 2025Exercised options 100,000 shares at $5.58 of Silverback Therapeutics⁶
• Sep 29, 2023Bought 46,258 shares at $3.78 of Silverback Therapeutics⁷
• Sep 28, 2023Bought 40,000 shares at $3.62 of Silverback Therapeutics⁷
• Feb 18, 2022Granted 300,000 shares of Evofem Biosciences, Inc.⁵
• Dec 31, 2021Returned to company 120,000 shares of Evofem Biosciences, Inc.⁸
• Dec 20, 2021Bought 25,000 shares at $0.39 of Evofem Biosciences, Inc.⁹